CG Oncology, Inc. Common stock (CGON) NASDAQ
53.72
-2.37(-4.23%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
53.72
-2.37(-4.23%)
Currency In USD
| Market Cap | 3.21B |
| Enterprise Value | 3.18B |
| P/E Ratio | -24.31 |
| PEG Ratio | 0.62 |
| Price/Sales Ratio | 934.38 |
| Price/Book Ratio | 4.16 |
| Enterprise/Revenue | 929.23 |
| Enterprise/EBITDA | -23.8 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -36.83 |
| Operating Margin | -42.39 |
| Return On Assets | -0.16 |
| Return On Equity | -0.23 |
| Revenue | 4.04M |
| Revenue/Share | 0.06 |
| Gross Profit | -607,000 |
| EBITDA | -159.55M |
| Net Income | -161M |
| Diluted EPS | -2.08 |
| Total Cash | 1.08B |
| Total Cash/Share | 12.73 |
| Total Debt | 7.58M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 31.3 |
| Book Value Per Share | 12.92 |
| 52-Week Change | 101.73 |
| 52-Week High | 75.5 |
| 52-Week Low | 23.65 |
| Moving Average 50 Days | 66.42 |
| Moving Average 200 Days | 50.15 |
| Average Volume | 1.23M |
| Shares Outstanding | 88.2M |
| % Held by Institutions | 114.01 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |